Clinical trials
Full profile accessFollow clinical development from study design and recruitment through results.
- Trial phase
- Status
- Readouts
Drug intelligence / Profile preview
Wharton Jelly mesenchymal stem cells (Sophia Al-Adwan)
- Development stage
- Unknown
- Lead developer
- Sophia Al-Adwan
- Modality
- Stem Cell Therapies → Cell Therapies
- Administration
- Intra-parenchymal
01
Overview
Wharton Jelly mesenchymal stem cells (WJ-MSCs) are multipotent stromal cells harvested from the mucoid connective tissue of the umbilical cord. In the clinical research program led by Sophia Al-Adwan, these cells are being investigated as a regenerative therapy for diabetic nephropathy. The treatment involves a specialized ultrasound-guided intra-parenchymal injection directly into the renal tissue. WJ-MSCs are characterized by their low immunogenicity and potent paracrine activity; they secrete a variety of anti-inflammatory cytokines, pro-angiogenic factors, and trophic molecules. This mechanism is intended to modulate the local immune environment, reduce chronic inflammation, and arrest or reverse the fibrotic damage to the kidneys typically seen in advanced diabetic kidney disease.
- Other names
- WJ-MSCsWharton's Jelly-derived mesenchymal stem cellsWharton Jelly Mesenchymal stem cells
Beyond the preview
Go deeper on Wharton Jelly mesenchymal stem cells (Sophia Al-Adwan).
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Indications & development
Full profile accessExplore development by indication, patient population, and geography.
- Indications
- Development status
- Countries
Licensing & deals
Full profile accessTrace asset ownership, licensing agreements, and commercial partnerships.
- Partners
- Deal terms
- Milestones
Patents & exclusivity
Full profile accessExplore the patent landscape and regulatory exclusivity around an asset.
- Patents
- Expiration dates
- Exclusivity
Competitive landscape
Full profile accessCompare development programs by target, modality, and indication.
- Competing assets
- Targets
- Development stage
Research & analysis
Full profile accessConnect source evidence and development news to your research questions.
- Publications
- News
- Analysis
Bring the full picture into focus.
See how Gosset can support your research on Wharton Jelly mesenchymal stem cells (Sophia Al-Adwan).